ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

In Brief: Mammography Quality assurance Act Introduced Laurence Marton Succeeds Brown At Wisconsin

November 1, 1991

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

AACR Grant Programs. NIH RFA Available.

June 29, 2001